PATENT CLAIM ANALYSIS

Application Number: 16192385
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "212040"]

Abstract:
The present invention relates to methods for treating hypercytokinemia and viral infections associated with hypercytokinemia using a mast cell stabilizing compound, optionally in combination with an antiviral agent. The invention further relates to compositions and dosage forms comprising mast cell stabilizing agents, optionally with an antiviral agent.

Claim (Index 10):
A method of treating or ameliorating a systemic inflammatory response associated with hypercytokinemia in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of norketotifen or a pharmaceutically acceptable salt thereof, thereby treating or ameliorating the systemic inflammatory response associated with hypercytokinemia.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 98.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15697835', '15816461', '10838338', '13793557', '15623585']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7393648468978784
- 35 USC 102 Novelty (BERT): 0.5532171618577949
- Combined Prediction Score: 0.7207500783938701
- Mean Citation Score: 247.304576
- Max Citation Score: 401.18015
- Similarity Product: 384.5132507200122

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test